These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 6231046
1. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Storb R, Prentice RL, Thomas ED, Appelbaum FR, Deeg HJ, Doney K, Fefer A, Goodell BW, Mickelson E, Stewart P. Br J Haematol; 1983 Dec; 55(4):573-85. PubMed ID: 6231046 [Abstract] [Full Text] [Related]
2. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. Storb R, Prentice RL, Thomas ED. N Engl J Med; 1977 Jan 13; 296(2):61-6. PubMed ID: 136605 [Abstract] [Full Text] [Related]
3. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP. Blood; 1982 Feb 13; 59(2):236-46. PubMed ID: 7034811 [Abstract] [Full Text] [Related]
4. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. Deeg HJ, Self S, Storb R, Doney K, Appelbaum FR, Witherspoon RP, Sullivan KM, Sheehan K, Sanders J, Mickelson E. Blood; 1986 Dec 13; 68(6):1363-8. PubMed ID: 3535930 [Abstract] [Full Text] [Related]
5. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia. Tsoi MS, Warren RP, Storb R, Witherspoon RP, Mickelson E, Giblett ER, Schanfield MS, Weiden P, Thomas ED. Exp Hematol; 1983 Jan 13; 11(1):73-81. PubMed ID: 6219886 [Abstract] [Full Text] [Related]
6. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor. Lohrmann HP, Dietrich M, Goldmann SF, Kristensen T, Fliedner TM, Abt C, Pflieger H, Flad HD, Kubanek B, Heimpel H. Blut; 1975 Dec 13; 31(6):347-54. PubMed ID: 1127 [Abstract] [Full Text] [Related]
7. Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? Storb R, Prentice RL, Banaji M, Witherspoon RP, Sullivan KM, Stewart P, Sanders JE, Mason M, Doney K, Deeg J, Clift RA, Buckner CD, Appelbaum FR, Thomas ED. Blood; 1983 Apr 13; 61(4):672-5. PubMed ID: 6338970 [Abstract] [Full Text] [Related]
8. Marrow transplant experience for children with severe aplastic anemia. Sanders JE, Storb R, Anasetti C, Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Hansen J. Am J Pediatr Hematol Oncol; 1994 Feb 13; 16(1):43-9. PubMed ID: 8311172 [Abstract] [Full Text] [Related]
9. Bone marrow transplantation experience for children with aplastic anemia. Sanders JE, Whitehead J, Storb R, Buckner CD, Clift RA, Mickelson E, Appelbaum FR, Bensinger WI, Stewart PS, Doney K. Pediatrics; 1986 Feb 13; 77(2):179-86. PubMed ID: 3511444 [Abstract] [Full Text] [Related]
10. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. Storb R, Prentice RL, Thomas ED. J Clin Invest; 1977 Apr 13; 59(4):625-32. PubMed ID: 14972 [Abstract] [Full Text] [Related]
11. Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia. Mickelson EM, Fefer A, Storb R, Thomas ED. Transplantation; 1976 Sep 13; 22(3):294-302. PubMed ID: 135386 [Abstract] [Full Text] [Related]
12. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR. Bone Marrow Transplant; 1996 Oct 13; 18(4):767-76. PubMed ID: 8899193 [Abstract] [Full Text] [Related]
13. Marrow graft rejection and inhibition of growth in culture by serum in aplastic anaemia. Barrett AJ, Faille A, Saal F, Balitrand N, Gluckman E. J Clin Pathol; 1978 Dec 13; 31(12):1244-8. PubMed ID: 372246 [Abstract] [Full Text] [Related]
14. Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine. Deeg HJ, Shulman HM, Schmidt E, Yee GC, Thomas ED, Storb R. Transplantation; 1986 Nov 13; 42(5):497-501. PubMed ID: 3538535 [Abstract] [Full Text] [Related]
15. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL. Ann Intern Med; 1980 Jan 13; 92(1):30-6. PubMed ID: 6985782 [Abstract] [Full Text] [Related]
16. Immunological studies in patients with aplastic anemia who rejected marrow grafts from HLA-identical sibling donors. Warren RP, Storb R, Thomas ED. Transplantation; 1982 Nov 13; 34(5):280-3. PubMed ID: 6760484 [Abstract] [Full Text] [Related]
17. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FA, Sanders JE, Stewart PS, Thomas ED. Ann Intern Med; 1983 Apr 13; 98(4):461-6. PubMed ID: 6340576 [Abstract] [Full Text] [Related]
18. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. Niederwieser D, Pepe M, Storb R, Loughran TP, Longton G. Br J Haematol; 1988 May 13; 69(1):23-8. PubMed ID: 3289603 [Abstract] [Full Text] [Related]
19. [Bone marrow transplantation in severe aplastic anemia and acute leukemia]. Speck B, Sartorius J, Cornu P, Nissen C, Weber W, Gratwohl A. Onkologie; 1979 Apr 13; 2(2):79-82. PubMed ID: 42865 [Abstract] [Full Text] [Related]
20. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors. Hamblin M, Marsh JC, Lawler M, McCann SR, Wickham N, Dunlop L, Ball S, Davies EG, Hale G, Waldmann H, Gordon-Smith EC. Bone Marrow Transplant; 1996 May 13; 17(5):819-24. PubMed ID: 8733704 [Abstract] [Full Text] [Related] Page: [Next] [New Search]